Navigation Links
Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting

#18064

About Pharmion

Pharmion is a biopharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic therapy, Vidaza(R); a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.

For more information or complete prescribing information about Vidaza, please call 1-866-PHARMION.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

The anticipated presentations described in this release will contain forward-looking statements, including summary statements relating to the results of clinical trials involving Pharmion's marketed and pipeline products. Such statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause the final results to differ significantly from the results summarized by such statements. The clinical trials that are the subject of the presentations described in this release are being conducted by independent investigators and Pharmion does not control and cannot predict the final results of those trials. Top line results may not be confirmed upon full analysis of the detailed results of a trial and additional information relating to the safety, efficacy or tolerability of Pharmion's products may be discovered upon further analysis of clinical trial data and upon review and analysis of additional clinical trial data. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2007, its Annual Report on Form 10-K for the y
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
(Date:11/25/2009)...ov.25/PRNewswire-FirstCall/--Formanyofthemillionso...vingwithuntreated hearingloss ,theholidaysmaynotbe...eyer,seniorvicepresidentofHearUSA(Amex: EAR ),oneo...ies,saidstudieshavelinkedhearinglosstostress,frust...fiedatholidaygatheringswithfamiliesandfriends,when...
(Date:11/25/2009)...,Nov.25/PRNewswire/--AMPACFineChemicalsLLC(AFC),as... )announcedtodaythatitreceivedtheEnvironmentalResp...deEnvironmentalSummit,sponsoredbytheCaliforniaManu...ialEnvironmentalAssociation(IEA)andtheChemicalIndu...themostprestigiousawardavailablefromallthreeorgani...
(Date:11/25/2009)...PRNewswire-Asia-FirstCall/--ChinaSkyOne,Medical,In...I ),a,leadingfullyintegratedpharmaceuticalcompanyd...ople,sRepublicofChina("PRC"),today,announcedthatth...or,theControlofPharmaceuticalandBiologicalProducts...gnosticKitforHumanProstateSpecific,Antigen(Colloid...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Platelet rich plasma 3A Does it work 3F 58610 1Platelet rich plasma 3A Does it work 3F 58610 2Platelet rich plasma 3A Does it work 3F 58610 3Strategy outlined for growing bioenergy while protecting wildlife 10204 1Entomological Society of America names 2009 award winners 10202 1Entomological Society of America names 2009 award winners 10202 2
...some fair coloring traits contribute to risk, of s...eCODEme(TM) service, REYKJAVIK, Iceland, May 18 ...nd academic colleagues from Europe and the U.S.,ex...etics of pigmentation,traits in people of European...mmon variants also confer risk of two types of ski...
...under-treated and under-studied population ... -, SAN DIEGO, Calif., May 18 Roche today announ...spective study to evaluate the,response of Latino ...(HCV),to combination therapy with pegylated interf... (peginterferon alfa-2a) in combination with,COPEG...
Other Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 2PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 3PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 4PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 5PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 6PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 7PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C 8
(Date:11/26/2009)... copper sequestering drug tetrathiomolybdate (TM) ...reatment of Wilson disease, a disease caused by an...s. That much is known. Very little, however, is kn...l. , A new study led by Northwestern University ...he three-dimensional structure of TM bound to copp...
(Date:11/26/2009)... Dr. David Kim of the Live Lif...urgery in Dallas , is one of a growing number of p...ial networking sites to connect with individuals w...t to fight morbid obesity. Dr. Kim is utilizing Fa...ation about his practice with the community. , ...
(Date:11/25/2009)..., EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--When...t.Butachiropractorcanalsogivepatientsthehelptheyne...whereyourjaw(mandible)contacts/connectswithyoursku...iatedwithTMJdysfunctionarepainwithchewing,clicking...romTMJdysfunctionincluding:headaches,fatigue,sleep...
(Date:11/25/2009)..., TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc...isualizationsoftwarelaunchesasuiteofnewleadingedge...ftwareplatformatthisyear,sRadiologicalSocietyofNor...,2009(Booth5800,HallA).Theapplicationsleveragetheu...alizedMRIimagingcoilsandsupportmultipleimagingmoda...
(Date:11/25/2009)..., SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQ...Winter Spare the Air Alert forThursd...dfirelogsoranyothersolidfuel,bothindoorsandoutdoor...hyairqualitytomorrow,"saidJackBroadbent,executiveo...storespectthehealthoftheirneighborsandfellowcommun...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...wered. They have now developed a new contraceptive...letely. The pill developed by New Jersey-based ...nplanned// pregnancies and the inconvenience of p...ight increase these risks and make it harder to sp...
... of a bus stand, they snap up conversations with c...ut the barbers // aren't quite indulging in idle ...vel initiative, 85 roadside barbers in the busy co...ry day. Ram Kumar, 25, runs a typical Indian...
...evision soaps or serials give a false picture abou...s. Researchers compiled 10 years data of suffering...e of survival and recovery shown in television soa... recovery rate is also controversial, in which the...
...dical Journal it was said that people in London ar... Money cannot bring you all the comforts and hap...the relationships that a happy and long life can b...g so hard that you've no time left for personal re...
... University School of Medicine in St. Louis has fo...rapidly after treatment and are not as depressed a...s of this study appear in the December issue of Su...dicine and Barnes-Jewish Hospital. All women were ...
...ylvania have obtained valuable insights into vario... technique // called functional magnetic resonance...reas of the brain that are active during an event ...in state progressively comes to resemble the state...
Other Medicine News:Health News:Snippy haircuts, snappier AIDS lessons from barbers 2Health News:Happiness Is Not Attained By A Wealthy Life But By A Healthy One. 2Health News:Magnetic Resonance Imaging Can Now Be Used For Mind Reading 2
... an advanced ophthalmic system that integrates bot...s to independently select either pump mode for Pha...is futuristic system is a microprocessor-controlle...ure, ensuring precise and linear vacuum control in...
SIL-5000-S® Silicone Oil - Syringe
SIL-5000® Silicone Oil
...y become a practice-changing technology for the as...nt of lower urinary tract symptoms (LUTS). Practic...on , Men unfit for surgery , Waiting list pati...UNA, Brachytherapy, Cryotherapy , LUTS different...
Medicine Products: